Rtog Foundation, Inc.

This study is for men whose prostate cancer shows signs of returning after surgery. It compares two treatment plans: radiation plus standard hormone therapy versus radiation plus a stronger, two-drug hormone therapy. The goal is to see if the more intensive approach keeps the can…

This study is for people whose head and neck cancer has come back or who have a new, related cancer in the same area. It is testing whether adding an immunotherapy drug (pembrolizumab/Keytruda) to a short, precise course of radiation is better at keeping the cancer from growing a…